Mark LeGolvan

478 citations
14 papers · 375 · h-index 10

Impact in

Papers in

Mark LeGolvan

14 papers receiving 348 citations

Peers

Mark LeGolvan
Comparison fields: 5 of 80
  • Polymers and Plastics 99
  • Biomaterials 59
  • Microbiology 3
  • Hepatology 21
  • Immunology 59
Replace Alexandra Rausch with:
Alexandra Rausch Germany
Jinghong Chen China
Jin Yong Kim South Korea
Michael Y. Chang United States
Boyang Sun China
Carlos Oliveira Portugal
Işıl Altıntaş Netherlands
Hai-Qiu Wu China
Alexandra Arranja Netherlands
Teresa Gonzalo Netherlands
Mark LeGolvan relative to Alexandra Rausch Germany Alexandra Rausch's profile →
Citations per field
00.5×
Alexandra Rausch · 1×
Citations per year

Countries citing papers authored by Mark LeGolvan

Since Specialization
Citations

This map shows the geographic impact of Mark LeGolvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark LeGolvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark LeGolvan more than expected).

Fields of papers citing papers by Mark LeGolvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark LeGolvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark LeGolvan. The network helps show where Mark LeGolvan may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark LeGolvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark LeGolvan Line = papers co-authored together Mark LeGolvan links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2004102
2 200376
3 201240
4 201037
5 201126
6 201224
7 201222
8 200715
9 201814
10 201010
11
Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy.
20144
12 20113
13 20201
14 20181

About Mark LeGolvan

Mark LeGolvan is a scholar working on Oncology, Pathology and Forensic Medicine, Surgery, Immunology and Epidemiology, having authored 14 papers that have together received 375 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers), Flame retardant materials and properties (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Colorectal and Anal Carcinomas (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Antifungal resistance and susceptibility (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Polymers and Plastics (99 citations), Biomaterials (59 citations), Microbiology (3 citations), Hepatology (21 citations) and Immunology (59 citations). Mark LeGolvan has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Alexander K. Andrianov, Murray B. Resnick, Jianping Chen, Ross Taliano, Chun‐Shiang Chung, Alfred Ayala, Sukamal Saha, Harold J. Wanebo, Markus Zuber and N. E. Kemeny. Their work appears in journals such as Human Pathology, Shock, Journal of Surgical Oncology, The Oncologist and Biomacromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact